Pyxis Oncology (PYXS) Assets Average (2021 - 2025)

Pyxis Oncology (PYXS) has 5 years of Assets Average data on file, last reported at $98.6 million in Q4 2025.

• On a quarterly basis, Assets Average fell 44.08% year-over-year to $98.6 million in Q4 2025; TTM through Dec 2025 was $98.6 million, a 44.08% decrease from a year earlier, with the FY2025 full-year figure at $124.4 million, down 24.84% from the prior year.
• Assets Average for Q4 2025 stood at $98.6 million, down from $114.4 million in the prior quarter.
• Over the last five years, Assets Average for PYXS reached as high as $266.4 million in Q1 2022 and fell as low as $98.6 million in Q4 2025.
• Historically, Assets Average has averaged $187.7 million across 5 years, with a median of $197.0 million in 2024.
• Across the five-year window, Assets Average grew 19.71% in 2024 and tumbled 44.08% in 2025, its largest moves.
• Year by year, Assets Average stood at $209.8 million in 2021, then grew by 3.76% to $217.6 million in 2022, then declined by 17.2% to $180.2 million in 2023, then decreased by 2.2% to $176.2 million in 2024, then tumbled by 44.08% to $98.6 million in 2025.
• Per Business Quant data, the three most recent Assets Average figures were $98.6 million in Q4 2025, $114.4 million in Q3 2025, and $129.5 million in Q2 2025.